Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Blood Cancer Drugs Global Market Report 2022
... blood cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Thyroid Cancer Drugs Global Market Report 2022
... thyroid cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Kidney Cancer Drugs Global Market Report 2022
... kidney cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
Ovarian Cancer Drugs Global Market Report 2022
... ovarian cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
2022 Global: Immunotherapy Drugs - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
Colorectal Cancer Drugs Global Market Report 2022
... colorectal cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
Gastric Cancer Drugs Global Market Report 2022
... gastric cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the ... Read More
-
Cervical Cancer Drugs Global Market Report 2022
... cervical cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Prostate Cancer Drugs Global Market Report 2022
... prostate cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Bladder Cancer Drugs Global Market Report 2022
... bladder cancer drugs market as it emerges from the Covid 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how ... Read More
-
Europe Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... and Biosimilar antibody products) The Europe next-generation antibody market is expected to reach US$ 3,162.30 million by 2028 from US$ 1,455.32 million in 2021. It is estimated to grow at a CAGR of 11.7% from ... Read More
-
Asia Pacific Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The Asia Pacific (APAC) next-generation antibody market is expected to reach US$ 2,312.68 million by 2028 from US$ 999.49 million in 2021. It is estimated to grow at a CAGR ... Read More
-
2022-2026 Succeeding in the Global Hematology and Flow Cytometry Market: US, Europe, Japan - Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers
... This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report ... Read More
-
2022-2026 Succeeding in the Italy Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... help current suppliers and potential market entrants identify and evaluate business opportunities emerging in Italian hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the Italian ... Read More
-
2022-2026 Succeeding in the France Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... help current suppliers and potential market entrants identify and evaluate business opportunities emerging in French hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the French ... Read More
-
2022-2026 Succeeding in the UK Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... help current suppliers and potential market entrants identify and evaluate business opportunities emerging in UK hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the UK ... Read More
-
Pharmaceutical Drugs Market Covering Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Central Nervous System Drugs; O
... 2021: Covid 19 Impact and Recovery The global pharmaceutical drugs market grew from $771.16 billion in 2015 to $975 billion in 2020 at a CAGR of 4.80%. The global pharmaceutical drugs market is expected to ... Read More
-
2022 Global Forecast for Oncology Nutrition (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Oncology Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem and Application - Analysis and Forecast, 2020-2031
... Digital Health and Information Technology, Precision Diagnostics Application - Solid Tumor and Hematological Malignancies Regional Segmentation North America: U.S., Canada Europe: Germany, France, Italy, U.K., Spain, and Rest-of- Europe Asia-Pacific: Japan, China, India, Australia, South ... Read More
-
Asia Pacific Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in APAC is expected ... Read More
-
Adoptive Cell Therapy Market, by Type (CAR-T, TCR-T, NK, and TIL), By Application (Lymphoma, Leukemia, and Others), by End User (Hospitals and Cancer Treatment Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Adoptive cell therapy (ACT) is a type of immunotherapy in which T cells (a type of immune cell) are given to ... Read More
-
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
... ganglioside GD2 is a major focus of drug developers. There are 131 drugs in the pipeline with 98% molecules present in early-to-mid stage. Mid-sized Pharma dominates clinical development in this space. More frequent use of ... Read More
-
Asia Pacific Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)
... Hospitals and Clinics, Specialty Clinics, and Home Care Services) The Asia Pacific (APAC) cervical cancer diagnostic testing market is expected to grow from US$ 936.22 million in 2021 to US$ 1,351.28 million by 2028. It ... Read More
-
Europe Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)
... and Clinics, Specialty Clinics, and Home Care Services) The Europe cervical cancer diagnostic testing market is expected to grow from US$ 1,368.86 million in 2021 to US$ 1,881.38 million by 2028. It is estimated to ... Read More
-
3D Medical Imaging Services Market by Technique (Ultrasound, X-ray, MRI, and Others), and Application (Oncology, Cardiology, Orthopedic, and Others): Global Opportunity Analysis and Industry Forecast, 2021––2030
... at $207,134.9 million in 2020, and is projected to reach $377,062.6 million by 2030, registering a CAGR of 6.6% from 2021 to 2030. 3D imaging is defined as a revolutionary optical imaging technology, which provides ... Read More
Research Assistance
